MacroGenics Gross Profit Margin vs Total Assets Analysis

MGNX Stock  USD 2.76  0.12  4.17%   
MacroGenics financial indicator trend analysis is infinitely more than just investigating MacroGenics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MacroGenics is a good investment. Please check the relationship between MacroGenics Gross Profit Margin and its Total Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MacroGenics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

Gross Profit Margin vs Total Assets

JavaScript chart by amCharts 3.21.1520162018202020222024-2.2-2.0-1.8-1.6-1.4-1.2-1.0-0.8-0.6-0.4-0.200.20.40.60.81.0 180M200M220M240M260M280M300M320M340M360M380M
JavaScript chart by amCharts 3.21.15Gross Profit Margintotal: -9.513350448251707Total Assetstotal: 3.8B

Gross Profit Margin vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MacroGenics Gross Profit Margin account and Total Assets. At this time, the significance of the direction appears to have weak relationship.
Gross Profit MarginTotal AssetsDiversified AwayGross Profit MarginTotal AssetsDiversified Away100%
The correlation between MacroGenics' Gross Profit Margin and Total Assets is 0.38. Overlapping area represents the amount of variation of Gross Profit Margin that can explain the historical movement of Total Assets in the same time period over historical financial statements of MacroGenics, assuming nothing else is changed. The correlation between historical values of MacroGenics' Gross Profit Margin and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit Margin of MacroGenics are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Gross Profit Margin i.e., MacroGenics' Gross Profit Margin and Total Assets go up and down completely randomly.

Correlation Coefficient

0.38
Relationship DirectionPositive 
Relationship StrengthVery Weak

Gross Profit Margin

Total Assets

Total assets refers to the total amount of MacroGenics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in MacroGenics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from MacroGenics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MacroGenics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MacroGenics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.At this time, MacroGenics' Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 247.74 in 2025, whereas Selling General Administrative is likely to drop slightly above 37 M in 2025.
 2022 2023 2024 2025 (projected)
Total Operating Expenses266.0M217.2M249.8M181.0M
Cost Of Revenue7.4M8.2M7.4M7.0M

MacroGenics fundamental ratios Correlations

0.320.410.95-0.140.78-0.31-0.5-0.56-0.110.720.810.380.20.950.380.830.740.170.520.750.290.520.99-0.290.83
0.320.310.240.170.330.010.03-0.290.20.070.340.120.080.260.20.170.480.230.20.30.30.250.29-1.00.18
0.410.310.190.140.70.240.06-0.720.630.140.690.320.540.210.420.60.720.40.650.710.740.70.32-0.280.6
0.950.240.19-0.350.6-0.49-0.64-0.32-0.220.780.670.430.190.960.230.660.51-0.080.450.53-0.030.320.97-0.210.66
-0.140.170.14-0.350.20.60.42-0.4-0.09-0.24-0.04-0.7-0.45-0.210.330.10.250.86-0.380.220.640.41-0.15-0.170.11
0.780.330.70.60.20.16-0.26-0.76-0.010.50.950.260.110.580.720.840.840.460.450.850.670.60.69-0.30.84
-0.310.010.24-0.490.60.160.44-0.370.24-0.390.03-0.46-0.03-0.510.670.060.190.5-0.050.190.54-0.01-0.37-0.020.06
-0.50.030.06-0.640.42-0.260.44-0.250.43-0.91-0.25-0.20.02-0.55-0.12-0.140.060.47-0.040.030.340.19-0.54-0.04-0.13
-0.56-0.29-0.72-0.32-0.4-0.76-0.37-0.25-0.32-0.09-0.74-0.19-0.31-0.35-0.59-0.85-0.91-0.75-0.63-0.93-0.82-0.8-0.480.26-0.86
-0.110.20.63-0.22-0.09-0.010.240.43-0.32-0.390.080.30.67-0.2-0.040.060.240.080.580.220.320.28-0.15-0.20.06
0.720.070.140.78-0.240.5-0.39-0.91-0.09-0.390.490.270.010.720.270.420.23-0.130.220.26-0.10.170.73-0.050.42
0.810.340.690.67-0.040.950.03-0.25-0.740.080.490.530.230.60.650.840.830.320.620.830.540.560.71-0.30.84
0.380.120.320.43-0.70.26-0.46-0.2-0.190.30.270.530.430.3-0.050.310.27-0.310.690.27-0.10.120.32-0.110.31
0.20.080.540.19-0.450.11-0.030.02-0.310.670.010.230.430.14-0.020.290.3-0.210.760.320.060.270.19-0.070.29
0.950.260.210.96-0.210.58-0.51-0.55-0.35-0.20.720.60.30.140.120.690.560.040.380.580.090.440.98-0.240.69
0.380.20.420.230.330.720.67-0.12-0.59-0.040.270.65-0.05-0.020.120.530.550.420.280.560.520.160.29-0.190.53
0.830.170.60.660.10.840.06-0.14-0.850.060.420.840.310.290.690.530.920.460.630.960.640.680.78-0.141.0
0.740.480.720.510.250.840.190.06-0.910.240.230.830.270.30.560.550.920.590.630.980.790.730.67-0.450.92
0.170.230.4-0.080.860.460.50.47-0.750.08-0.130.32-0.31-0.210.040.420.460.590.040.580.80.730.12-0.220.48
0.520.20.650.45-0.380.45-0.05-0.04-0.630.580.220.620.690.760.380.280.630.630.040.650.290.450.46-0.180.63
0.750.30.710.530.220.850.190.03-0.930.220.260.830.270.320.580.560.960.980.580.650.780.740.69-0.280.96
0.290.30.74-0.030.640.670.540.34-0.820.32-0.10.54-0.10.060.090.520.640.790.80.290.780.680.2-0.280.65
0.520.250.70.320.410.6-0.010.19-0.80.280.170.560.120.270.440.160.680.730.730.450.740.680.48-0.220.69
0.990.290.320.97-0.150.69-0.37-0.54-0.48-0.150.730.710.320.190.980.290.780.670.120.460.690.20.48-0.270.78
-0.29-1.0-0.28-0.21-0.17-0.3-0.02-0.040.26-0.2-0.05-0.3-0.11-0.07-0.24-0.19-0.14-0.45-0.22-0.18-0.28-0.28-0.22-0.27-0.15
0.830.180.60.660.110.840.06-0.13-0.860.060.420.840.310.290.690.531.00.920.480.630.960.650.690.78-0.15
Click cells to compare fundamentals

MacroGenics Account Relationship Matchups

MacroGenics fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets378.7M335.2M280.5M298.4M343.2M287.5M
Other Current Liab26.2M24.4M19.5M24.2M27.9M29.3M
Total Current Liabilities50.7M74.6M48.6M56.1M64.5M47.8M
Total Stockholder Equity295.9M239.6M142.0M152.6M175.5M199.6M
Other Liab9.2M6.9M258K59.7M53.8M56.5M
Property Plant And Equipment Net42.2M37.7M56.9M45.7M52.5M32.9M
Current Deferred Revenue11.4M20.6M69.5M21.7M24.9M22.3M
Net Debt(151.9M)(98.0M)(74.1M)(67.0M)(60.3M)(63.3M)
Retained Earnings(771.8M)(973.9M)(1.1B)(1.1B)(992.5M)(942.9M)
Accounts Payable8.0M15.5M4.9M6.4M7.4M6.1M
Cash181.1M123.5M108.9M101.0M116.1M146.4M
Non Current Assets Total66.1M55.7M58.3M47.1M54.1M40.8M
Non Currrent Assets Other23.9M18.0M(7.7M)1.4M1.6M1.5M
Other Assets23.9M335.2M1.4M1.01.151.09
Cash And Short Term Investments272.5M243.6M154.3M229.8M264.3M224.7M
Net Receivables23.1M10.4M56.2M10.4M11.9M14.4M
Common Stock Total Equity490K562K613K617K709.6K396.0K
Common Stock Shares Outstanding52.4M59.9M61.4M61.9M71.2M42.1M
Liabilities And Stockholders Equity378.7M335.2M280.5M298.4M343.2M287.5M
Non Current Liabilities Total32.2M21.0M89.8M89.7M103.2M108.3M
Other Current Assets34.0M42.3M10.2M9.9M11.4M11.0M
Other Stockholder Equity1.1B1.2B1.2B1.3B1.4B774.0M
Total Liab82.9M95.6M138.5M145.8M167.7M87.9M
Property Plant And Equipment Gross42.2M110.5M29.6M134.1M154.2M161.9M
Total Current Assets312.6M279.6M222.2M251.3M289.0M246.7M
Accumulated Other Comprehensive Income(3K)16K(7K)(6K)(6.9K)(7.2K)
Short Term Debt8.0M9.4M9.5M3.8M3.4M3.2M
Common Stock562K613K617K621K714.2K418.1K
Property Plant Equipment68.4M42.2M37.7M29.6M34.0M30.8M
Short Long Term Debt Total29.2M25.5M34.8M34.0M39.1M41.0M
Net Tangible Assets230.6M295.9M239.6M142.0M163.3M245.6M
Short Term Investments91.4M120.1M45.5M128.8M148.2M91.7M
Capital Surpluse872.2M1.1B1.2B1.2B1.4B817.2M
Net Invested Capital295.9M239.6M142.0M152.6M137.4M183.2M
Net Working Capital261.9M205.0M173.6M195.2M175.7M172.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.

Trending Assets

MLYS
Mineralys Therapeutics,
9.56  0.24  2.58 
NGM
NGM Biopharmaceuticals
0.00  0.00  0.00 
ANTX
AN2 Therapeutics
1.13  -0.02  -1.74 
DAWN
Day One Biopharmaceu
12.43  0.20  1.64 
News Freq…Investor S…